九州大学 研究者情報
研究者情報 (研究者の方へ)入力に際してお困りですか?
基本情報 研究活動
飯森 真人(いいもり まこと) データ更新日:2020.10.01

准教授 /  薬学研究院


研究業績
主要原著論文
1. Yuki Kataoka, Makoto Iimori, Ryo Fujisawa, Tomomi Morikawa-Ichinose, Shinichiro Niimi, Takeshi Wakasa, Hiroshi Saeki, Eiji Oki, Daisuke Miura, Toshiki Tsurimoto, Yoshihiko Maehara, Hiroyuki Kitao, DNA Replication Stress Induced by Trifluridine Determines Tumor Cell Fate According to p53 Status, Molecular Cancer Research, 10.1158/1541-7786.MCR-19-1051, 18, 9, 1354-1366, 2020.09.
2. Sei Shu, Makoto Iimori, Takeshi Wakasa, Koji Ando, Hiroshi Saeki, Yoshinao Oda, Eiji Oki, Yoshihiko Maehara, The balance of forces generated by kinesins controls spindle polarity and chromosomal heterogeneity in tetraploid cells, Journal of cell science, 10.1242/jcs.231530, 132, 24, 2019.01, [URL].
3. Yuki Kataoka, Makoto Iimori, Shinichiro Niimi, Hiroshi Tsukihara, Takeshi Wakasa, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Hiroyuki Kitao, Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level, Scientific reports, 10.1038/s41598-019-44399-6, 9, 1, 2019.12, [URL].
4. Yasuo Tsuda, Makoto Iimori, Yuichiro Nakashima, Ryota Nakanishi, Kouji Andou, Kippei Ohgaki, Hiroyuki Kitao, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Mitotic slippage and the subsequent cell fates after inhibition of Aurora B during tubulin-binding agent-induced mitotic arrest, Scientific Reports, 10.1038/s41598-017-17002-z, 7, 1, 2017.12, [URL].
5. Hajime Otsu, Makoto Iimori, Kouji Andou, Hiroshi Saeki, Shinichi Aishima, Yoshinao Oda, Masaru Morita, Keitaro Matsuo, Hiroyuki Kitao, Eiji Oki, Yoshihiko Maehara, Gastric Cancer Patients with High PLK1 Expression and DNA Aneuploidy Correlate with Poor Prognosis, Oncology, 10.1159/000445952, 91, 1, 31-40, 2016.07, [URL].
6. Makoto Iimori, Sugiko Watanabe, Shinichi Kiyonari, Kazukaki Matsuoka, Ryo Sakasai, Hiroshi Saeki, Eiji Oki, Hiroyuki Kitao, Yoshihiko Maehara, Phosphorylation of EB2 by Aurora B and CDK1 ensures mitotic progression and genome stability, Nature Communications, 10.1038/ncomms11117, 7, 2016.03, [URL].
7. Shinichi Kiyonari, Makoto Iimori, Kazuaki Matsuoka, Sugiko Watanabe, Tomomi Morikawa-Ichinose, Daisuke Miura, Shinichiro Niimi, Hiroshi Saeki, Eriko Tokunaga, Eiji Oki, Masaru Morita, Kenji Kadomatsu, Yoshihiko Maehara, Hiroyuki Kitao, The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis, Molecular Cancer Therapeutics, 10.1158/1535-7163.MCT-14-0748, 14, 10, 2332-2342, 2015.10, [URL].
8. Kazuaki Matsuoka, Makoto Iimori, Shinichiro Niimi, Hiroshi Tsukihara, Sugiko Watanabe, Shinichi Kiyonari, Mamoru Kiniwa, Kouji Andou, Eriko Tokunaga, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Hiroyuki Kitao, Trifluridine induces p53-dependent sustained G2 phase arrest with its massive misincorporation into DNA and few DNA strand breaks, Molecular Cancer Therapeutics, 10.1158/1535-7163.MCT-14-0236, 14, 4, 1004-1013, 2015.01, [URL].
9. Makoto Iimori, Kanako Ozaki, Yuji Chikashige, Yasushi Hiraoka, Takahisa Maki, Ikuko Hayashi, Chikashi Obuse, Tomohiro Matsumoto, A mutation of the fission yeast EB1 overcomes negative regulation by phosphorylation and stabilizes microtubules, Experimental Cell Research, 10.1016/j.yexcr.2011.11.006., 318, 3, 262-275, 2012.02, [URL].
研究資金
科学研究費補助金の採択状況(文部科学省、日本学術振興会)
2017年度~2019年度, 基盤研究(C), 代表, 細胞分裂を完了させる新規切断因子の分子制御機構.
2013年度~2015年度, 若手研究(B), 代表, 新たに発見した微小管結合性抗癌剤に対する細胞応答の分子機構解明と創薬標的の探索.
競争的資金(受託研究を含む)の採択状況
2016年度~2018年度, 公益財団法人 新日本先進医療研究財団, 代表, 抗がん剤による老化誘導シグナルの分子機構解明と創薬標的の探索.

九大関連コンテンツ

pure2017年10月2日から、「九州大学研究者情報」を補完するデータベースとして、Elsevier社の「Pure」による研究業績の公開を開始しました。
 
 
九州大学知的財産本部「九州大学Seeds集」